Emerging therapeutic strategies for chronic inflammatory diseases.
The 6th edition of the "Days of Molecular Medicine" conference was held at the Karolinska Institute in Stockholm, Sweden, May 24-27, 2006, and focused on the role of inflammation in chronic disease. The meeting, organized by The Nature Publishing Group, the Massachusetts General Hospital and the Karolinska Institute, brought together an international panel of speakers who discussed recent advances in the molecular pathology of chronic inflammatory diseases. This congress report summarizes the most relevant presentations highlighting novel targets for therapeutic intervention.
Ferrer
Elisa
E
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy / Q000378:metabolism; D050197:Atherosclerosis / Q000188:drug therapy / Q000378:metabolism; D002908:Chronic Disease; D006801:Humans; D007249:Inflammation / Q000188:drug therapy* / Q000378:metabolism*; D015212:Inflammatory Bowel Diseases / Q000188:drug therapy / Q000378:metabolism; D009103:Multiple Sclerosis / Q000188:drug therapy / Q000378:metabolism; D011565:Psoriasis / Q000188:drug therapy / Q000378:metabolism; D015398:Signal Transduction / Q000187:drug effects
D000893:Anti-Inflammatory Agents